Raluca Verona

12PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 02, 2026
Teclistamab and Daratumumab Immune-Based Doublet Therapy for Relapsed/Refractory Multiple Myeloma: the TRIMM-2 Study.

|Sep 22, 2025
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study.

Ajai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria

|Aug 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1.

Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk

|Feb 26, 2025
Mechanisms of Response and Resistance to PSMA×CD3 Bispecifics in CD34+ Humanized Mice.

Bethany K Mattson Cypert, Krista Menard, Gerald Chu

|Aug 22, 2024
Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.

Cyrille Touzeau, Amrita Y Krishnan, Philippe Moreau

|Apr 30, 2024
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.

Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans

Pageof 2

Frequent Collaborators

4 joint publications

Nizar J Bahlis

3 joint publications

Maria-Victoria Mateos

3 joint publications

Paula Rodriguez-Otero

2 joint publications

Bhagirathbhai Dholaria